Scientists Uncover Fatal Weakness in “Zombie Cells” Linked to Cancer

Researchers screened 10,000 compounds and found drugs that selectively kill senescent cells by disabling GPX4, a key defense against ferroptosis.

The work points to a new senolytic strategy that could remove therapy-resistant “zombie cells” linked to tumor growth, spread, and inflammation.

Published in Nature Cell Biology by teams at the MRC Laboratory of Medical Sciences and Imperial College London, the findings may also matter for aging-related diseases.